Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Junji Hiraga
Observed names:
J Hiraga,
Junji HIRAGA
Institution:
Toyota Kosei Hospital
Observed institutions:
Toyota Memorial Hospital,
National Hospital Organization,
Toyota Kosei Hospital,
Nagoya Medical Center,
Nagoya University
ORCID:
0000-0002-1845-4786
Observed ORCID:
0000-0002-1845-4786
OpenAlex ID:
A5044099774
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
2009
·
Junji Hiraga
, Akihiro Tomita
, et al.
·
Blood
·
271
PDF
Malignant histiocytosis‐like B‐cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature
1997
·
Takuhei Murase
, Shigeo Nakamura
, et al.
·
British Journal of Haematology
·
112
Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
2007
·
Akihiro Tomita
, Junji Hiraga
, et al.
·
International Journal of Hematology
·
60
Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation
2009
·
Takumi Sugimoto
, Akihiro Tomita
, et al.
·
Biochemical and Biophysical Research Communications
·
54
Clinical significance of nuclear non‐phosphorylated beta‐catenin in acute myeloid leukaemia and myelodysplastic syndrome
2008
·
Jinglan Xu
, Momoko Suzuki
, et al.
·
British Journal of Haematology
·
45
PDF
A Case of Interstitial Pneumonia Induced by Rituximab Therapy
2005
·
Junji Hiraga
, Yasuhiro Kondoh
, et al.
·
International Journal of Hematology
·
34
Loss of O 6 -Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
2006
·
Toshihito Ohno
, Junji Hiraga
, et al.
·
International Journal of Hematology
·
28
Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma
2007
·
J Hiraga
, A Katsumi
, et al.
·
Leukemia
·
25
A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag
2017
·
Naruko Suzuki
, Junji Hiraga
, et al.
·
International Journal of Hematology
·
24
Promoter Hypermethylation of the DNA-Repair Gene O 6 -Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
2006
·
Junji Hiraga
, Tomohiro Kinoshita
, et al.
·
International Journal of Hematology
·
24
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial
2018
·
Takashi Watanabe
, Kensei Tobinai
, et al.
·
The Lancet Haematology
·
23
Treatments and Outcomes of Newly Diagnosed CD5‐Positive Diffuse Large B‐Cell Lymphoma: A Multi‐Institutional Observational Study
2025
·
Yuma Nato
, Kana Miyazaki
, et al.
·
Hematological Oncology
·
13
PDF
Expression of programmed cell death ligand‐1 by immune cells in the microenvironment is a favorable prognostic factor for primary diffuse large B‐cell lymphoma of the central nervous system
2020
·
Yuta Tsuyuki
, Eri Ishikawa
, et al.
·
Neuropathology
·
12
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab
2018
·
Junji Hiraga
, Akihiro Tomita
, et al.
·
Annals of Hematology
·
8
Retention of CD34+ CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
2012
·
Y Minami
, A Abe
, et al.
·
Leukemia
·
8
PDF
Successful immunosuppressive and iron chelation therapy for a severe aplastic anemia patient undergoing hemodialysis due to chronic renal failure
2011
·
Junji Hiraga
, Reona Sakemura
, et al.
·
International Journal of Hematology
·
6
Immune thrombocytopenia induced by vonoprazan fumarate: a single center retrospective study
2017
·
Naruko Suzuki
, Junji Hiraga
, et al.
·
Annals of Hematology
·
3
EBV-positive Diffuse Large B-cell Lymphoma as a Secondary Malignancy Arising in a Myelodysplastic Syndrome Patient who Was Treated with Azacitidine
2017
·
Naruko Suzuki
, Junji Hiraga
, et al.
·
Internal Medicine
·
3
PDF
Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma
2026
·
Yuma Nato
, Kana Miyazaki
, et al.
·
Annals of Hematology
·
2
PDF
Treatment and outcomes of pulmonary mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients
2026
·
Kazutaka Suzuki
, Kana Miyazaki
, et al.
·
Cancer
·
2
Treatment and Outcomes of Stage I-II Pulmonary MALT Lymphoma: A Multi-Institutional Observational Study in Japan
2024
·
Kazutaka Suzuki
, Kana Miyazaki
, et al.
·
Blood
·
2
PDF
Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan
2023
·
Yuma Nato
, Kana Miyazaki
, et al.
·
Blood
·
2
PDF
Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
2018
·
Shin Nagai
, Junji Hiraga
, et al.
·
Case Reports in Hematology
·
2
PDF
Epigenetic Regulation of CD20 Protein Expression in B-Cell Lymphoma Cells after Rituximab-Containing Chemotherapy.
2007
·
Akihiro Tomita
, Junji Hiraga
, et al.
·
Blood
·
2
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era
2025
·
Akinao Okamoto
, Masahiro Yoshida
, et al.
·
Frontiers in Oncology
·
1
PDF
Show more works
View as search
Works count:
59
Citation count:
775
H-index:
12
I10-index:
13
Year
Topic
Type